Bibliographic information
GuidelineWHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders
Year of Publication2012
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
TB patients with known positive HIV status and TB patients living in HIV-prevalent settings should receive at least 6 months of rifampicin treatment regimen (strong recommendation, high quality of evidence). The optimal dosing frequency is daily during the intensive and continuation phases
Recommended in favor
Strong
Certainty of evidence
High
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization